サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1561656

ボツリヌス毒素市場レポート：タイプ、用途、エンドユーザー、地域別、2024年～2032年

Botulinum Toxin Market Report by Type (Toxin Type A, Toxin Type B), Application (Therapeutics, Aesthetics), End User (Hospitals and Clinics, Dermatology Clinics, Spas and Cosmetic Centers), and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
ボツリヌス毒素市場レポート：タイプ、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のボツリヌス毒素市場の市場規模は2023年に58億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに107億米ドルに達し、2024年から2032年の間に6.7%の成長率（CAGR）を示すと予測しています。

ボツリヌス毒素は、ボツリヌス菌によって産生される神経毒であり、嫌気性、グラム陽性、芽胞形成性の桿菌で、植物、土壌、水、動物の腸管によく見られます。ボツリヌス菌は、さまざまな病状の管理において重要な役割を果たしています。これらの疾患には、斜視や局所性ジストニア、半顔面痙攣、頭痛、唾液分泌過多、多汗症、痙性運動障害などが含まれます。さらに、利用可能な医学的治療に部分的にしか反応しないさまざまな慢性疾患の治療にも利用されています。現在では、眉間のしわ、顔、あご、首、胸のしわを一時的に軽減する美容目的にも使用されています。

ボツリヌス毒素市場動向：

慢性および急性疾患の有病率および診断の大幅な増加は、市場の成長を後押しする重要な要因の1つです。ボツリヌス毒素は、活動し過ぎの平滑筋、腺の異常な活動、多汗症などの皮膚科学的症状の治療に幅広く応用されています。さらに、個人の美意識の高まりと、再建手術や美容整形手術を受ける意欲が、市場の成長に寄与しています。加えて、ソーシャルメディアの影響力の増大、急速な都市化、1人当たり所得の上昇と相まって、美容ツーリズムの新たな動向が市場にプラスの影響を与えています。これとは別に、皮膚は加齢とともにシワやたるみの影響を受けやすくなるため、老年人口の増加と若く健康な皮膚を保ちたいという願望が市場の成長を後押ししています。さらに、異なる血清型を組み合わせて新しい強力な毒素を開発することで、総単位と全体の抗原量を減らし、有効性と効果時間を改善することができます。このような進歩は、市場に明るい展望をもたらすと予測されます。

本レポートで扱う主な質問

  • 2023年の世界のボツリヌス毒素市場の市場規模は？
  • 2024年～2032年の世界のボツリヌス毒素市場の予想成長率は？
  • 世界のボツリヌス毒素市場に対するCOVID-19の影響は？
  • 世界のボツリヌス毒素市場を牽引する主要因は何か？
  • 世界のボツリヌス毒素市場のタイプ別内訳は？
  • 世界のボツリヌス毒素市場の用途別内訳は？
  • 世界のボツリヌス毒素市場のエンドユーザー別内訳は？
  • ボツリヌス毒素市場の世界における主要地域は？
  • 世界のボツリヌス毒素市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のボツリヌス毒素市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 毒素タイプA
    • 市場動向
    • 市場予測
  • 毒素タイプB
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 治療
    • 市場動向
    • 市場予測
  • 美容
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院と診療所
    • 市場動向
    • 市場予測
  • 皮膚科クリニック
    • 市場動向
    • 市場予測
  • スパとコスメティックセンター
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Eisai Co. Ltd
    • Evolus Inc
    • Galderma SA
    • HUGEL Inc.
    • Ipsen Group
    • Medytox Inc.
    • Merz Pharma GmbH & Co. KGaA
    • Metabiologics Inc.
    • Revance Therapeutics Inc.
図表

List of Figures

  • Figure 1: Global: Botulinum Toxin Market: Major Drivers and Challenges
  • Figure 2: Global: Botulinum Toxin Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Botulinum Toxin Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Botulinum Toxin Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Botulinum Toxin Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Botulinum Toxin Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Botulinum Toxin Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Botulinum Toxin (Toxin Type A) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Botulinum Toxin (Toxin Type A) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Botulinum Toxin (Toxin Type B) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Botulinum Toxin (Toxin Type B) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Botulinum Toxin (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Botulinum Toxin (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Botulinum Toxin (Aesthetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Botulinum Toxin (Aesthetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Botulinum Toxin (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Botulinum Toxin (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Botulinum Toxin (Dermatology Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Botulinum Toxin (Dermatology Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Botulinum Toxin (Spas and Cosmetic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Botulinum Toxin (Spas and Cosmetic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: United States: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: United States: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Canada: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Canada: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia-Pacific: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia-Pacific: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: China: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: China: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Japan: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Japan: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: India: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: India: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: South Korea: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: South Korea: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Australia: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Australia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Indonesia: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Indonesia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Europe: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Europe: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Germany: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Germany: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: France: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: France: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United Kingdom: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United Kingdom: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Italy: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Italy: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Spain: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Spain: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Russia: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Russia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Brazil: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Brazil: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Mexico: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Mexico: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Botulinum Toxin Market: Breakup by Country (in %), 2023
  • Figure 70: Middle East and Africa: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: Botulinum Toxin Industry: SWOT Analysis
  • Figure 72: Global: Botulinum Toxin Industry: Value Chain Analysis
  • Figure 73: Global: Botulinum Toxin Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Botulinum Toxin Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Botulinum Toxin Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Botulinum Toxin Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Botulinum Toxin Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Botulinum Toxin Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Botulinum Toxin Market: Competitive Structure
  • Table 7: Global: Botulinum Toxin Market: Key Players
目次
Product Code: SR112024A4453

The global botulinum toxin market size reached US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.

Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum, which is an anaerobic, gram-positive, spore-forming rod commonly found in plants, soil, water, and intestinal tracts of animals. It plays a significant role in the management of a wide variety of medical conditions. These conditions include strabismus and focal dystonia, hemifacial spasm, headaches, hypersalivation, hyperhidrosis, and spastic movement disorders. Moreover, it is utilized in the treatment of various chronic diseases that respond partially to available medical treatments. Nowadays, it is also used for the cosmetic purpose of temporarily reducing frown lines, creases, and wrinkles on the face, chin, neck, and chest.

Botulinum Toxin Market Trends:

A significant rise in the prevalence and diagnosis of chronic and acute diseases represents one of the key factors bolstering the market growth. Botulinum toxin finds extensive applications in the treatment of dermatological conditions, such as overactive smooth muscles, abnormal activity of glands, and hyperhidrosis. Moreover, the rising beauty consciousness among individuals, along with their willingness to undergo reconstructive and cosmetic surgeries, is contributing to market growth. In addition, the emerging trend of cosmetic tourism, in confluence with the increasing influence of social media, rapid urbanization, and inflating per capita income, is influencing the market positively. Apart from this, as the skin becomes more susceptible to wrinkles and sagging with age, the growing geriatric population and the desire to retain young and healthy skin are bolstering the market growth. Furthermore, the development of new potent toxins by combining different serotypes can reduce the total units and overall antigenic dose and improve effectiveness and duration of effect. These advancements are projected to create a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global botulinum toxin market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end user.

Breakup by Type:

  • Toxin Type A
  • Toxin Type B

Breakup by Application:

  • Therapeutics
  • Aesthetics

Breakup by End User:

  • Hospitals and Clinics
  • Dermatology Clinics
  • Spas and Cosmetic Centers

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Eisai Co. Ltd, Evolus Inc, Galderma SA, HUGEL Inc., Ipsen Group, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Metabiologics Inc. and Revance Therapeutics Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global botulinum toxin market in 2023?
  • 2. What is the expected growth rate of the global botulinum toxin market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global botulinum toxin market?
  • 4. What are the key factors driving the global botulinum toxin market?
  • 5. What is the breakup of the global botulinum toxin market based on type?
  • 6. What is the breakup of the global botulinum toxin market based on the application?
  • 7. What is the breakup of the global botulinum toxin market based on the end user?
  • 8. What are the key regions in the global botulinum toxin market?
  • 9. Who are the key players/companies in the global botulinum toxin market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Botulinum Toxin Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Toxin Type A
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Toxin Type B
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Aesthetics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Dermatology Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Spas and Cosmetic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Eisai Co. Ltd
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Evolus Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Galderma SA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 HUGEL Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Ipsen Group
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medytox Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Merz Pharma GmbH & Co. KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Metabiologics Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Revance Therapeutics Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials